Introduction
Pre-eclampsia is a major pregnancy complication leading to substantial maternal and perinatal morbidity and mortality worldwide. 1, 2 Pre-eclampsia is a multi-system disorder with variable clinical manifestations which include hypertension and proteinuria. For the mother, pre-eclampsia is associated with various pregnancy complications, long-term cardiovascular morbidity and maternal death. It is also associated with preterm birth, fetal growth restriction, perinatal death and long-term adult health problems in the offspring. 2 Pre-eclampsia affects 2-7% of healthy nulliparous women. Although its etiology is poorly understood, 3 pre-eclampsia is most common at the extremes of maternal age, in first pregnancies, multi-fetal pregnancies 2, 4, 5 and among women with a history of pre-eclampsia. 6, 7 Pre-eclampsia may progress to eclampsia, characterised by life-threatening convulsions that generally occur after mid-pregnancy and around birth.
Rates of pre-eclampsia and gestational hypertension have increased in the USA from 1987 to 2004 by 25% and 184%, respectively, although eclampsia has not. 8 The contribution of international migration to population estimates of hypertensive disorders in pregnancy and their secular trends in industrialised countries is unknown. According to a recent systematic review, the incidence of pre-eclampsia and eclampsia varies five-and 26-fold worldwide, respectively. 9 Despite regional variations, few studies have reported variations in pre-eclampsia among immigrants to industrialised countries according to maternal birthplace or ethnic origin and almost none in eclampsia. [10] [11] [12] [13] [14] These studies were based on a single setting, such as a hospital, 12, 13 midwife practices, 15 a city, 10, 11 or a province 14 and used different definitions of the outcomes and migrant groups. Conclusions regarding disparities according to immigrants' maternal birthplace based on single-site studies may not be generalisable to other settings. In contrast, multi-country studies using uniform ascertainment of the outcomes and immigrant groups, such as this one, provide a more robust approach to identifying maternal regions of origin associated with higher (and lower) global risk of pre-eclampsia and eclampsia in receiving countries.
The aim of this study was to assess disparities in pre-eclampsia and eclampsia among immigrants residing in six high-immigration countries according to their maternal region of origin. We compared immigrants from specific regions of the world to Western European immigrants, the sub-population which is ethnically closer to those born in the receiving countries while it shares the experience of migration. We subsequently assessed within-country disparities comparing immigrants from diverse regions of the world to the non-immigrant populations in each of the receiving countries.
Materials and methods

Study design
This is a cross-country comparative study. We used population-based regional or national health data from six countries (Australia, Canada, Denmark, Spain, Sweden and the USA). The study protocol was specified prior to data collection. Participating centres had to meet the following inclusion criteria: (i) ascertainment of pre-eclampsia and eclampsia by either the International Classification of Diseases, Injuries and Causes of Death, 9th Revision (ICD-9) 16 or the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10); 17 (ii) categorisation of maternal region of origin according to pre-specified groupings by maternal country of birth; (iii) provision of population-based aggregated data (number of cases and non-cases) stratified by maternal region of birth, parity and maternal age groups.
Study populations and data sources
The study population was composed of any obstetrical delivery (including live births and stillbirths) of immigrants and non-immigrants occurring within the most recent 10-year period available to each participating centre (Table  S1 ), although not all centres contributed 10 years of data. The study populations included deliveries from Australia (the state of Victoria), Canada (province of Ontario), Denmark and Sweden (national data), Spain (provinces of Catalonia and Valencia) and the USA (California, New Jersey and New York City). Population health data were obtained from perinatal data collections, health care registers and birth certificates linked to hospital records. These databases have been previously used for perinatal research and have been found to be of good quality. [18] [19] [20] [21] [22] [23] [24] [25] Each participating centre was responsible for assessing the internal consistency and quality of the definitions in the data sets across years and jurisdictions and to obtain ethical approval to share the data for pooled analyses. The study protocol was approved by the Research Ethics Board of the St. Michael's Hospital, Toronto, Canada.
Outcome measures
We defined pre-eclampsia based on the International Classification of Diseases (ICD) criteria available to each participating country. Spain and the USA used the ICD-9 codes 642.4 (Mild or unspecified pre-eclampsia), 642.5 (Severe pre-eclampsia) and 642.6 (Eclampsia), and the remaining countries used the ICD-10 codes O11 (Pre-existing hypertensive disorder with superimposed proteinuria), O14 [Gestational (pregnancy-induced) hypertension with significant proteinuria, including moderate, severe and unspecified pre-eclampsia and HELLP syndrome] and O15 (Eclampsia).
Pre-eclampsia with prolonged hospital stay (PPHS) was defined as any pre-eclampsia with a length of hospital stay greater than or equal to 7 days, as a proxy for more serious cases of pre-eclampsia associated with a higher burden on health care services. PPHS was not reported for Denmark due to data quality concerns and for Sweden due to the unavailability of data.
Maternal region of birth
Information on maternal country of birth was used to create maternal world regions of origin, based on the United Nations subregions. 26 Groups were as follows: Eastern Europe, Western Europe, Latin America & the Caribbean, North Africa & Middle East, Sub-Saharan Africa, South Asia, and East-Southeast Asia. North America and Oceania were not included because of small numbers of immigrants from these regions. Two comparison groups were used. To assess differences according to immigrants' region of origin in analyses restricted to immigrants, Western Europeans were the reference group. This approach allows quantification of the variation in the outcomes that exists among immigrant groups. To assess disparities within each receiving country, the reference group was composed of the receiving country-born: USA-born in the USA, Australian-born in Australia, and so on. This approach is more appropriate to assess how different immigrant groups fare compared with the majority non-immigrant populations of the respective receiving countries.
Covariates
We included maternal age and parity as potential confounders. Because maternal age has a J-or U-shape association with severe maternal morbidity 5, 27 we created two groupings to capture the excess risk associated with the extremes of the maternal age distribution: <20 years or ≥35 years versus 20-34 years as the reference group. Parity was dichotomised in primiparous versus multiparous women as the reference group. Inclusion of additional covariates or more detailed strata of maternal age and parity were not feasible due to restrictions on disclosing small cell sizes in some participating countries.
Statistical analyses
Count data (number of cases and non-cases of each outcome) were provided by each participating centre by strata of maternal region of origin, maternal age and parity in a spreadsheet. These count data were merged into a single data set per outcome with the addition of a receiving country identifier. Each resulting data set was then imported into and analysed with SAS 9.3© (SAS Institute, Cary, NC, USA).
It has been suggested that international comparisons of absolute population rates of pre-eclampsia and eclampsia may not be meaningful because of different diagnostic criteria and methods of data collection. 5, 28 However, comparing relative rates between different immigrant groups and the non-immigrant population across countries of destination overcomes the limitations of comparing absolute rates, assuming that the probability of being diagnosed does not substantially differ according to immigration status.
We performed two analyses. The first analysis was restricted to immigrants to assess the variability in pre-eclampsia and eclampsia according to maternal region of origin. We used a two-level logistic regression model with deliveries (first level) nested within receiving countries (second level). The model included random intercepts to account for the variability of the outcome between receiving countries. This model is similar to a meta-analysis in which jurisdictions occupy the place of studies. 29, 30 California, New Jersey and New York City were treated as distinct second-level clusters to account for differences between these jurisdictions. This was not possible for the provinces of Catalonia and Valencia, as the Spanish data were not disaggregated by province. Heterogeneity of outcome rates between receiving countries was assessed by the median odds ratio (MOR). 31 The MOR translates the country-level variance into the widely used odds ratio scale, which is easier to interpret. Here, the MOR shows the extent to which a woman's risk of pre-eclampsia is determined by the receiving countries. The MOR can be conceptualised as the increased risk that (in median) a woman would have if moving to another country with a higher risk. In addition, one-sided Wald tests were used to obtain P-values for the significance of the variances.
The second set of analyses compared different immigrant groups with the non-immigrant population within each receiving country. For this purpose we used ordinary logistic regression stratified by receiving country to obtain within-country estimates and a two-level model with deliveries nested within receiving countries to obtain a pooled estimate across countries. Regression models were run before and after adjustment for maternal age and parity. Effect estimates were odds ratios with 95% confidence intervals. In post-hoc analyses, we assessed the extent of the disparities according to world region of origin by calculating odds ratios between the group with the highest incidence versus the group with the lowest incidence within each country.
Finally, we performed sensitivity analyses using detailed Ontario individual data. The purpose was twofold; to disaggregate Caribbean, Central American and South American women as three different groups, and to explore the potential impact of unmeasured confounders in the pooled estimates, by considering a more complete set of maternal characteristics, including those associated with migration (knowledge of official Canadian languages, maternal education at migration, marital status, refugee status and duration of residence in Canada).
Results
There were 9 028 802 deliveries across the six receiving countries, 3 031 399 (33.6%) of which were to immigrant women (Table S2 ). The proportion of deliveries to immigrant women varied across countries, from 12.6% in Denmark to 43.5% in the USA, mainly driven by 1 187 393 Latin Americans in California, mostly of Mexican origin. To test whether differences between world regions varied between receiving countries, we further included region of origin as random slopes in a subsequent model (not shown). A statistically significant variance of the slopes, although small, suggested that disparities according to maternal region of origin varied between receiving countries, which justifies the assessment of disparities within each receiving country (Table S3 ). The MOR was 1.4 for pre-eclampsia and 1.5 for eclampsia, indicating moderate heterogeneity between receiving countries, which did not reach statistical significance according to the Wald test. The Wald test was only significant for PPHS, which had an MOR of 1.8, suggesting slightly higher heterogeneity. However, this model was also based on a smaller sample, as it did not include Denmark or Sweden, making it less stable. Table S3 shows the results of separate ordinary logistic regression analyses conducted within strata of receiving countries. Here the reference group is the majority non-immigrant population of each receiving country. The excess risk of women from Latin America and the Caribbean and Sub-Saharan Africa was not observed equally in all countries when compared with that in women born in the receiving country. Women from Sub-Saharan Africa had a higher risk of pre-eclampsia and PPHS in all countries, the only exception being Australia. The higher risk of eclampsia among women from Sub-Saharan Africa was also observed in all countries but only reached statistical significance in Spain and Sweden. A comparable pattern was observed for women from Latin America and the Caribbean, although not in Sweden. Immigrants from that region were at lower risk of pre-eclampsia in Denmark.
Disparities between maternal regions of birth
Disparities within receiving countries
The remaining maternal regions of origin were associated with lower odds than receiving-country women in all countries except Spain, where only Western European women had lower odds than Spanish-born women. Pooled analyses show that, compared with women born in the receiving country, Sub-Saharan Africans and those from Latin America & the Caribbean were at consistently higher risk of the three outcomes. Conversely, the remaining migrant groups were at lower risk than locally born women. The magnitude of disparities within countries, however, was in part affected by the baseline risk of the locally born reference group in each country. To better reflect the extent of disparities by maternal birthplace in each country we also compared the groups with the highest versus the lowest level of the outcomes. Spain exhibited the highest disparities according to maternal region of birth, with odds ratios between the groups with the highest versus the lowest incidence ranging from 4.6 for pre-eclampsia to 12.9 for eclampsia. Australia had the lowest disparities, with odds ratios between the groups with the highest versus the lowest incidence in the range of 1.5-2.0.
Sensitivity analyses using Ontario data (Table S4) show that associations were stronger for women from the Caribbean and Central America than for women from South America, whose outcome rates were not higher than those of Western Europeans. Inclusion of additional maternal characteristics, including immigration characteristics, did not substantially alter the observed associations. Interestingly, time since immigration was positively associated with pre-eclampsia (adjusted 10-year OR 1.14, 95% CI 1.06, 1.23) but negatively associated with eclampsia (adjusted 10-year OR 0.79, 95% CI 0.59, 1.05), although the latter did not reach statistical significance.
Discussion
Main findings
Our main finding is that women from Sub-Saharan Africa had the highest risk of pre-eclampsia and eclampsia in all six participating countries, followed by women from Latin America & the Caribbean. The remaining maternal regions of birth were not associated with increased risk of the outcomes, and some exhibited lower risk than in women born in the respective receiving countries. We also found that disparities between maternal regions of birth varied substantially between receiving countries, being lowest in Victoria, Australia, and highest in Catalonia/Valencia, Spain. The non-immigrant populations generally had incidence rates somewhere in the middle of the continuum of risk.
Strengths and limitations
Study strengths include the use of large population-based data sets, the combination of data collected from six high-immigration countries and the use of standardised definitions of outcomes and migrant groups.
Limitations illustrate the challenges faced by cross-country comparative studies. We relied on perinatal data collections, health care registers and linked databases from different countries, which differ in some characteristics that may impact the absolute rates of the outcomes. However, as our analyses are based on the relative disparities according to maternal region of birth, variations in absolute rates are of less concern.
Whereas reporting systems in Australia, Canada, Denmark and Sweden used the ICD-10, Spain and the USA used the ICD-9. This difference in coding schemes did not result in different incidence rates. The incidence rates of pre-eclampsia and eclampsia in the countries using the ICD-9 (Spain and the USA) were within the range observed in the countries using the ICD-10.
Our assumption that the probability of being diagnosed does not substantially differ according to immigration status may not hold equally true in all participating countries, some of which do not have universal health care coverage, such as the USA. Although we controlled for extreme maternal age and parity, we could not include other covariates such as multiple pregnancies, history of pre-eclampsia, health care access and socioeconomic indicators or health behaviours, due to either lack of information or to restrictions on reporting low event counts in some countries. However, our sensitivity analyses based on Ontario data suggest that inclusion of a larger set of additional covariates, including maternal education, official language ability and neighbourhood income, would not explain the observed associations. Moreover, adjustment for mediators such as health behaviours or social position in the receiving society may not be appropriate and may result in overcontrol. In the same vein, the ability to create more detailed groupings of maternal origin, ideally at country level, was hampered by sample size considerations and consistency across participating countries. Different distribution of countries within maternal world regions may be responsible in part for the differences observed between receiving countries. In addition, most participating countries do not collect data on ethnicity and generational status, which may have unveiled more complex disparities, particularly among the more ethnically diverse non-immigrant populations. National data were only available for Denmark and Sweden; therefore the findings for the remaining countries, although regionally valid, may not necessarily be representative of the country as a whole.
Interpretation
Despite these limitations, our findings provide robust evidence of an increased global risk of pre-eclampsia and eclampsia among immigrants from Sub-Saharan Africa and Latin America and the Caribbean.
Disparities between maternal regions of birth
The excess risk found among Sub-Saharan Africans may be a reflection of background risks in the source countries. In fact, Sub-Saharan Africans exhibit the highest rates of pre-eclampsia, eclampsia 9 and maternal mortality worldwide, 32 and migrants may carry over their higher susceptibility post-migration. Generalisation regarding Sub-Saharan Africans to other Western countries is supported not only by our findings but also by studies conducted in Belgium, 11 the Netherlands 15 and Italy. 33 However, generalisations should be made with caution, as unique processes may occur in different immigration settings. The exception of Victoria, Australia, in the case of pre-eclampsia may be an example. Potential factors that may help explain it include the impact of selective admission policies, which may have excluded less healthy individuals who might otherwise have inflated the numerators, 34, 35 a pool of immigrants different from those of the other countries and the existence of a more equitable socioeconomic environment.
Immigrants from Latin America & the Caribbean had lower odds of pre-eclampsia in Denmark and similar odds in Sweden. The relatively lower incidence of pre-eclampsia in these countries may be due to a different composition of specific countries of origin. In fact, Denmark and Sweden have mainly received immigrants from South America; countries from South America, like Argentina, have been shown to be associated with lower rates of pre-eclampsia compared with those of Central America and the Caribbean. 10 Our sensitivity analyses using Ontario data, showing increased risks for Caribbean and Central American women but not for South American women, are consistent with these previous findings. Therefore, generalisation regarding Latin American and Caribbean women must be cautious and attention must be paid to the composition of specific source-countries in a given receiving setting. Although unexplored, proximity of country of origin to country of delivery may be a factor influencing selective migration patterns. For example, geographical proximity may favour less selected migration of Mexicans into the USA, including undocumented migrants, compared with Mexicans migrating overseas. The same may apply to Africans in Spain compared with Africans settling in North America.
The remaining immigrant groups from Europe, Asia and North Africa & Middle East had a similar or lower incidence of pre-eclampsia and eclampsia than Western Europeans and noticeably lower incidence than the non-immigrant populations; this pattern being consistent with the healthy migrant effect. 36 Disparities within receiving countries Within-country analyses also provide evidence of a higher vulnerability of Sub-Saharan African women in most countries, followed by those of Latin America and the Caribbean. Interestingly, Europeans, North Africans and Asians had lower incidence of pre-eclampsia and eclampsia than some locally born populations, which had intermediate risk of the outcomes.
Because the varying baseline risk of locally born women in each receiving country affects the comparison of disparities between countries, we also compared the groups at the extremes of the continuum of risk and found the greatest disparities in Catalonia/Valencia, Spain, and the smallest in Victoria, Australia.
The high disparities in Catalonia/Valencia may be due to contrasting influxes of better-off, and therefore healthier, Western Europeans on one end of the continuum of risk and immigrants from poor regions in the other end, including many Latin Americans and North and Sub-Saharan Africans in irregular situations and living in marginalised conditions, thus increasing the differences. 37, 38 Spain has witnessed an immigration boom at the turn of the 21st century, 39 implying that many immigrants to Spain are newcomers who may not be familiar with the local environment and health care system. It is possible that some Western Europeans with complicated pregnancies may have chosen to deliver in the more supportive environment of their home countries, which may be facilitated by low travel costs within Europe and easier access to high quality health care. If supported by empirical evidence, this phenomenon would represent a particular case of the 'salmon bias', by which some immigrants groups appear to be healthier than they really are because ill individuals who return to their birthplace for treatment no longer contribute to the numerators. 36 On the other hand, Spain also hosts a sizeable undocumented immigrant population, estimated at around 25% among female immigrants aged 20-40 years. 40 An undocumented status may expose women to exploitation and stress, and hamper their ability to seek and properly utilise health care. 41 However, illegal stay cannot be the only explanation as it occurs in varying degrees in all countries. Finally, discrimination adds another layer of disadvantage that might contribute to higher disparities, particularly among racialised groups. 42 The lowest disparities observed in Victoria are puzzling and may be due to factors operating simultaneously. First, selective migration policies may have contributed to flattening the disparities via a healthy migrant effect. 36 The Australian Humanitarian Program admits many African refugees only after medical and security checks but admits relatively few asylum seekers from Africa. 34 The General Skilled Migration Program selects immigrants on the basis of skills and qualifications in demand in the Australian job market. 35 Such selective admission policies may result in the exclusion of less healthy women who otherwise may have contributed to increased rates of pre-eclampsia and eclampsia. It is also possible that narrower material deprivation gradients observed among Australian immigrants 43 could account for less disparity in the Victorian findings, compared with other receiving regions with wider income disparities related to migrant status, such as Canada. 44 Interestingly, the Ontario data show that the risk of pre-eclampsia increased with duration of residence but that of eclampsia decreased. Increases in pre-eclampsia may due to deterioration of health status following migration, a process already observed for preterm delivery, 45 whereas decreases in eclampsia may reflect that more cases of eclampsia were prevented over time by timely health care, probably parallel to increased integration of immigrants in the local society.
Conclusion
Our findings provide robust evidence of an increased global risk of pre-eclampsia and eclampsia among Sub-Saharan African immigrants and some Latin American or Caribbean groups. Clinicians are encouraged to consider these high-risk groups for pre-eclampsia and eclampsia in need of enhanced surveillance and culturally sensitive peripartum care.
Future research aimed at generating global evidence about immigrants' determinants of health would benefit from adopting an international comparative approach, based on standardised measurements and more detailed individual data to unveil the mechanisms behind the associations, including access to and health care utilisation, particularly for at-risk pregnancies. Ideally, although challenging, research should also use longitudinal data and include pre-migration measurements to account for selective migration and assess changes in the receiving countries.
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